Asymmetry Capital Management, L.P. - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 204 filers reported holding HERON THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 2.25 and the average weighting 0.5%.

Quarter-by-quarter ownership
Asymmetry Capital Management, L.P. ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$727,000
-56.2%
39,273
-42.2%
1.56%
-43.8%
Q1 2019$1,660,000
+107.2%
67,909
+120.0%
2.77%
+25.4%
Q4 2018$801,000
-54.7%
30,861
-44.7%
2.21%
+35.5%
Q3 2018$1,768,000
-31.6%
55,847
-16.0%
1.63%
-35.7%
Q2 2018$2,583,000
+21.0%
66,488
-14.0%
2.54%
-4.9%
Q1 2018$2,135,000
+18.9%
77,346
-22.0%
2.67%
+9.6%
Q4 2017$1,795,000
+76.5%
99,181
+57.5%
2.44%
+106.6%
Q3 2017$1,017,00062,9621.18%
Other shareholders
HERON THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
TANG KEVIN C 21,288$250,00019.87%
TANG CAPITAL MANAGEMENT LLC 2,896,904$34,010,0004.78%
PFM Health Sciences, LP 2,481,917$29,138,0002.39%
Iron Triangle Partners LP 500,000$5,870,0002.27%
NEXPOINT ASSET MANAGEMENT, L.P. 777,599$9,129,0001.72%
Pekin Hardy Strauss, Inc. 588,732$6,912,0001.55%
First Light Asset Management, LLC 691,400$8,117,0001.39%
Congress Park Capital LLC 111,045$1,304,0001.18%
Mesirow Financial Investment Management, Inc. 15,135$178,0001.12%
Elk Creek Partners, LLC 509,174$5,978,0001.03%
View complete list of HERON THERAPEUTICS INC shareholders